Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal dominant disease characterized by adult-onset of liver cysts arising from the bile duct epithelium, caused by heterozygous mutation in the LRP5 gene. Some patients may develop a few kidney cysts, but these are often incidental and do not result in renal failure.
Features include common findings: Renal cyst and Hepatic cysts.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 1 | Renal cyst |
Digestive system |
LRP5 encodes LDL receptor related protein 5 (1,615 aa). Acts as a coreceptor with members of the frizzled family of seven-transmembrane spanning receptors to transduce signal by Wnt proteins. Highest expression in Artery Aorta (83.2 TPM) and Artery Tibial (67.8 TPM).
Polycystic liver disease 4 with or without kidney cysts has limited evidence linking it to mutations in the LRP5 gene on chromosome 11.
The LRP5 protein participates in LRP5 D666_L809del, Signaling by LRP5 mutants, and Negative regulation of TCF-dependent signaling by WNT ligand antagonists pathways.
LRP5 is classified as a druggable target with score 0.0.
Genetic testing for LRP5 is available. Testing is considered research-grade for diagnosis.
Biomarker and diagnostic research for polycystic liver disease 4 with or without kidney cysts has been reported in the published literature.
Phenotype severity distribution: 2 common features.
No clinical trials have been registered for polycystic liver disease 4 with or without kidney cysts.
203 publications have been identified in PubMed for polycystic liver disease 4 with or without kidney cysts. Kisho has analyzed 133 by research type. Research spans Review / Meta-Analysis (29%), Basic Science / Preclinical (27%), and Epidemiology / Natural History (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 38 | 29% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 5:34 PM UTC
Online Mendelian Inheritance in Man
Hepatic cysts |
Age of onset: adulthood.
Laboratory research |
36 |
27% |
Disease patterns and progression | 19 | 14% |
Patient case studies | 14 | 11% |
New treatment approaches | 14 | 11% |
Testing and diagnosis research | 7 | 5% |
Clinical study results | 3 | 2% |
Other research | 2 | 2% |
Kang Z (2026). [PMID: 41632353](https://pubmed.ncbi.nlm.nih.gov/41632353/). *Arch Pharm Res*. [Epidemiology / Natural History]
Zhu Z (2026). [PMID: 41576700](https://pubmed.ncbi.nlm.nih.gov/41576700/). *Redox Biol*. [Basic Science / Preclinical]
Duijzer R (2026). [PMID: 40793999](https://pubmed.ncbi.nlm.nih.gov/40793999/). *Liver Transpl*. [Epidemiology / Natural History]
Rowe I (2026). [PMID: 41513925](https://pubmed.ncbi.nlm.nih.gov/41513925/). *Sci Rep*. [Basic Science / Preclinical]
Garfield K (2026). [PMID: 29763075](https://pubmed.ncbi.nlm.nih.gov/29763075/). *Unknown Journal*. [Basic Science / Preclinical]
Xue C (2026). [PMID: 41431718](https://pubmed.ncbi.nlm.nih.gov/41431718/). *Genes Dis*. [Review / Meta-Analysis]
Khaddour K (2026). [PMID: 30480964](https://pubmed.ncbi.nlm.nih.gov/30480964/). *Unknown Journal*. [Epidemiology / Natural History]
D'Amico S (2026). [PMID: 41507385](https://pubmed.ncbi.nlm.nih.gov/41507385/). *Sci Rep*. [Basic Science / Preclinical]
Zheng Q (2026). [PMID: 41501598](https://pubmed.ncbi.nlm.nih.gov/41501598/). *Hum Mol Genet*. [Basic Science / Preclinical]
Takahashi J (2026). [PMID: 41263668](https://pubmed.ncbi.nlm.nih.gov/41263668/). *Cancer Discov*. [Basic Science / Preclinical]